Inventor · disambiguated record
Piotr Raubo
Also filed as: RAUBO PIOTR · RAUBO PIOTR A · RAUBO PIOTR ANTONI
16 granted patents·7 pending applications·49 citations·filing 1998–2024
90Inventor score
Top patents by PatentIndex Score
23 records- 0185US10040788B21,3,4-thiadiazole compounds and their use in treating cancerASTRAZENECA AB·Filed 2015·Granted Aug 7, 2018·6 cites·14 claims
- 0281US10294221B21, 3, 4-thiadiazole compounds and their use in treating cancerASTRAZENECA AB·Filed 2018·Granted May 21, 2019·3 cites·11 claims
- 0377US8163905B2Compounds and their uses 708BROUGH STEPHEN·Filed 2008·Granted Apr 24, 2012·2 cites·4 claims
- 0476US10040789B21,3,4-thiadiazole compounds and their use in treating cancerASTRAZENECA AB·Filed 2016·Granted Aug 7, 2018·3 cites·16 claims
- 0571US8299246B2N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their usesBROUGH STEPHEN·Filed 2012·Granted Oct 30, 2012·1 cites·4 claims
- 0670US8889692B2Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their usesBROUGH STEPHEN·Filed 2012·Granted Nov 18, 2014·1 cites·12 claims
- 0769US2024270757A1Spirocyclic compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0868US6727249B2Azabicyclic ether derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Apr 27, 2004·4 cites·16 claims
- 0965US6555552B2Azabicyclic amine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Apr 29, 2003·3 cites·19 claims
- 1065US6225320B1Spiro-azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1998·Granted May 1, 2001·24 cites·19 claims
- 1162US7101892B2Sulfone derivatives as 5-HT7 receptor ligandsMERCK SHARP & DOHME·Filed 2004·Granted Sep 5, 2006·2 cites·11 claims
- 1262US2015073136A1Pyrazinone derivativesASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1360US2022127281A1Heteroaryl compounds that inhibit g12c mutant ras proteinsASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 1455US2010056508A1Amine derivatives and their use in beta-2-adrenoreceptor mediated diseasesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1554US8017602B2N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapyASTRAZENECA AB·Filed 2009·Granted Sep 13, 2011·0 cites·12 claims
- 1653US2012142646A1Novel Compounds 621ALCARAZ LILIAN·Filed 2007·Application pending·0 cites
- 1745US8163956B2Inhibitors of GLYT1 transportersBLACKABY WESLEY PETER·Filed 2006·Granted Apr 24, 2012·0 cites·11 claims
- 1845US8012979B2Compounds and their uses 707ASTRAZENECA AB·Filed 2008·Granted Sep 6, 2011·0 cites·13 claims
- 1945US2020109153A1Heteroaryl compounds that inhibit g12c mutant ras proteinsASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2043US7393858B2Tetrahydropyran compounds as tachykinin antagonistsMERCK SHARP & DOHME·Filed 2004·Granted Jul 1, 2008·0 cites·9 claims
- 2141US6906085B2Tetrahydropyran derivatives as neurokinin receptor antagonistsMERCK SHARP & DOHME·Filed 2002·Granted Jun 14, 2005·0 cites·14 claims
- 2240US2005261285A1Tetrahydropyran derivatives and their use as therapeutic agentsDIRAT OLIVIER·Filed 2003·Application pending·0 cites
- 2339US6479486B2Azabicyclic spiroether derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Nov 12, 2002·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →